Skip to content
Tenfell
Awarded contract
Published 21 May 2020

NHS National Framework Agreement for Adalimumab Injection

NHS England · London

Key facts

Awarded
06 Mar 2020
Contract starts
31 Mar 2020
Contract ends
31 Mar 2022
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 4 suppliers

SupplierValue
FRESENIUS KABI LIMITED—
Abbvie Ltd—
Amgen Ltd—
Biogen—

Description

NHS Framework Agreement for Adalimumab Injection Offer reference number: CM/PHR/19/5575

Period of Framework Agreement: 1 April 2020 - 31 March 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.